latest episodes ↓
EP103: Gene Writing with Tessera Therapeutics CEO, Dr. Mike Severino
Patrick is joined by Dr. Mike Severino, CEO of Tessera Therapeutics and CEO-Partner of Flagship Pioneering. Join us as Mike walks us through Tessera’s approach to treating genetic diseases by rewriting bases, exons, or even whole genes with a novel approach called Gene Writing.
Get in touch
We’ll respond to you within one working day
Want to see more?
Delve into the details of our work with reports on condition areas, industry trends, and more.
Gain insights into the current landscape of precision medicine and clinical research.
Tune in to the leading genetics podcast for hot topics in biomarker-led drug development.